JP2023540171A5 - - Google Patents

Info

Publication number
JP2023540171A5
JP2023540171A5 JP2023506220A JP2023506220A JP2023540171A5 JP 2023540171 A5 JP2023540171 A5 JP 2023540171A5 JP 2023506220 A JP2023506220 A JP 2023506220A JP 2023506220 A JP2023506220 A JP 2023506220A JP 2023540171 A5 JP2023540171 A5 JP 2023540171A5
Authority
JP
Japan
Prior art keywords
solution composition
pharmaceutical solution
composition according
ics
laba
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023506220A
Other languages
English (en)
Japanese (ja)
Other versions
JP7828949B2 (ja
JP2023540171A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2021/071369 external-priority patent/WO2022023515A1/en
Publication of JP2023540171A publication Critical patent/JP2023540171A/ja
Publication of JP2023540171A5 publication Critical patent/JP2023540171A5/ja
Application granted granted Critical
Publication of JP7828949B2 publication Critical patent/JP7828949B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023506220A 2020-07-31 2021-07-30 吸入投与のための併用療法 Active JP7828949B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP20382710.0 2020-07-31
EP20382710 2020-07-31
PCT/EP2021/071369 WO2022023515A1 (en) 2020-07-31 2021-07-30 Combination therapy for inhalation administration

Publications (3)

Publication Number Publication Date
JP2023540171A JP2023540171A (ja) 2023-09-22
JP2023540171A5 true JP2023540171A5 (cg-RX-API-DMAC7.html) 2025-11-27
JP7828949B2 JP7828949B2 (ja) 2026-03-12

Family

ID=72039503

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023506220A Active JP7828949B2 (ja) 2020-07-31 2021-07-30 吸入投与のための併用療法

Country Status (13)

Country Link
US (1) US20230270754A1 (cg-RX-API-DMAC7.html)
EP (1) EP4188327B1 (cg-RX-API-DMAC7.html)
JP (1) JP7828949B2 (cg-RX-API-DMAC7.html)
KR (1) KR20230052903A (cg-RX-API-DMAC7.html)
CN (1) CN115989032A (cg-RX-API-DMAC7.html)
AU (1) AU2021314977B2 (cg-RX-API-DMAC7.html)
BR (1) BR112023001689A2 (cg-RX-API-DMAC7.html)
CA (1) CA3186956A1 (cg-RX-API-DMAC7.html)
ES (1) ES3037198T3 (cg-RX-API-DMAC7.html)
FI (1) FI4188327T3 (cg-RX-API-DMAC7.html)
MX (1) MX2023001201A (cg-RX-API-DMAC7.html)
PL (1) PL4188327T3 (cg-RX-API-DMAC7.html)
WO (1) WO2022023515A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4188327B1 (en) 2020-07-31 2025-05-28 Chemo Research, S.L. Combination therapy for inhalation administration
WO2026057872A1 (en) * 2024-09-16 2026-03-19 Invox Belgium Nv Inhalable compositions
CN121714579A (zh) * 2026-02-25 2026-03-24 上海臣邦医药科技股份有限公司 一种三联复方吸入制剂的药物组合物及其制备方法和应用

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4851317A (en) 1987-11-04 1989-07-25 E. I. Du Pont De Nemours And Company Laminar flow toning station having conductive and nonconductive elements therein
BR9609307B1 (pt) 1995-06-27 2010-03-09 preparação farmacêutica para produção de aerossóis inaláveis isentos de propelentes para administração nos pulmões, bem como aerossol compreendendo a mesma.
DE19536902A1 (de) 1995-10-04 1997-04-10 Boehringer Ingelheim Int Vorrichtung zur Hochdruckerzeugung in einem Fluid in Miniaturausführung
DE19653969A1 (de) 1996-12-20 1998-06-25 Boehringer Ingelheim Kg Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole
DK1121112T3 (da) * 1998-10-17 2002-09-16 Boehringer Ingelheim Pharma Lagringsdygtigt koncentrat af aktivt stof med formoterol
EE05167B1 (et) 2000-05-22 2009-06-15 Chiesi Farmaceutici S.P.A. Stabiilsed farmatseutilised lahuspreparaadid survestatud doseerivatele inhalaatoritele
FI20002215A0 (fi) 2000-10-06 2000-10-06 Orion Yhtymae Oyj Yhdistelmäpartikkelit
FI20002216A0 (fi) 2000-10-06 2000-10-06 Orion Yhtymae Oyj Yhdistelmäpartikkelit astman hoitoon
US20020137764A1 (en) * 2000-10-31 2002-09-26 Karin Drechsel Inhalable formulation of a solution containing a tiotropium salt
CA2733294C (en) 2000-10-31 2011-12-20 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical combination of a tiotropium salt and ciclesonide
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
EP1879571A1 (de) 2005-04-23 2008-01-23 Boehringer Ingelheim International GmbH Arzneimittelkombination für die inhalation enthaltend neben einem anticholinergikum ein betamimetikum und ein steroid
ITMI20051999A1 (it) * 2005-10-21 2007-04-22 Eratech S R L Formulazioni inalatorie di farmaci in fora di polvere secca per somministrazione come tale o con nebulizzatore e dotate di elevata erogabilita' respirabilita' e stabilita'
US20070293460A1 (en) 2005-10-31 2007-12-20 Richie's Pharmacy And Medical Supply, Incorporated Delivery of a combination therapy for asthma and chronic obstructive pulmonary disease
US20070098644A1 (en) 2005-10-31 2007-05-03 Richie's Pharmacy And Medical Supply, Incorporated Delivery of a combination therapy for asthma and chronic obstructive pulmonary disease
DE102006023756A1 (de) 2006-05-20 2007-11-29 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ethanolhaltige Aerosolformulierung für die Inhalation
UY30542A1 (es) 2006-08-18 2008-03-31 Boehringer Ingelheim Int Formulacion de aerosol para la inhalacion de agonistas beta
HRP20140582T4 (hr) 2009-12-23 2023-06-09 Chiesi Farmaceutici S.P.A. Kombinacijska terapija za copd
WO2011076841A2 (en) 2009-12-23 2011-06-30 Chiesi Farmaceutici S.P.A. Combination therapy for copd
SG181870A1 (en) 2009-12-23 2012-07-30 Chiesi Farma Spa Aerosol formulation for copd
US20120220557A1 (en) 2011-02-17 2012-08-30 Chiesi Farmaceutici S.P.A. Liquid propellant-free formulation comprising an antimuscarinic drug
HRP20181980T1 (hr) 2012-12-21 2019-01-25 Boehringer Ingelheim Vetmedica Gmbh Ciklezonid za liječenje dišnih puteva kod konja
JP6534397B2 (ja) 2013-12-30 2019-06-26 シエシー ファルマセウティチィ ソシエタ ペル アチオニ グリコピロニウム臭化物およびホルモテロールの組合せの安定な加圧エアゾール溶液組成物
AU2014375301C1 (en) * 2013-12-30 2026-02-19 Chiesi Farmaceutici S.P.A. Stable pressurised aerosol solution composition of glycopyrronium bromide and formoterol combination
US9554992B2 (en) 2014-06-09 2017-01-31 Chiesi Farmaceutici S.P.A. Inhalation particles comprising a combination of an anticholinergic, a corticosteroid and a beta-adrenergic
WO2015193213A1 (en) 2014-06-18 2015-12-23 Boehringer Ingelheim Vetmedica Gmbh Muscarinic antagonists and combinations thereof for the treatment of airway disease in horses
GB201520862D0 (en) * 2015-11-25 2016-01-13 Jagotec Ag Pharmaceutical composition
US10098837B2 (en) * 2016-07-28 2018-10-16 Chiesi Farmaceutici S.P.A. Combination therapy for COPD
WO2020167893A1 (en) 2019-02-13 2020-08-20 Molecular Infusions, Llc Methods for non-irritating pulmonary administration of cannabinoids using soft mist inhalers
EP4188327B1 (en) 2020-07-31 2025-05-28 Chemo Research, S.L. Combination therapy for inhalation administration

Similar Documents

Publication Publication Date Title
US20170027908A1 (en) Pharmaceutical Composition
AU2011315315B2 (en) Pharmaceutical composition
JP2024525567A5 (cg-RX-API-DMAC7.html)
WO2014016548A2 (en) Pharmaceutical composition
HRP20140864T1 (hr) Kombinacije koje sadrže antimuskarinska sredstva i beta-adrenergiäśke agoniste
WO2004019985A1 (en) Pharmaceutical products and compositions comprising specific anticholinergic agents, beta-2 agonists and corticosteroids
JP2013542940A5 (cg-RX-API-DMAC7.html)
NZ600789A (en) Aerosol formulation for copd
JP2016503390A (ja) 医薬組成物
JP2019528316A5 (cg-RX-API-DMAC7.html)
FI4188327T3 (fi) Yhdistelmähoito inhalaatioannosteluun
FI3500241T3 (fi) Yhdistelmähoito copd:lle
TWI922835B (zh) 預防或治療呼吸系統疾病的吸入用藥物組合物
CN106470700A (zh) 用于治疗copd的噻托溴铵、福莫特罗和布地奈德的组合
CN104955448A (zh) 适用于吸入治疗的包含多组分结晶颗粒的药物组合物
HRP20140818T1 (hr) Farmaceutske aerosolne formulacije formoterola i beklometazon-dipropionata
EP3400214B1 (en) Dry powder inhaler compositions of 7-azoniabicyclo[2.2.1]heptane derivatives
AU2015275933A1 (en) Pharmaceutical composition comprising a beta-2-agonist and anticholinergic agent
JP2024546201A (ja) サルブタモールを含む医薬組成物
JP2025517809A5 (cg-RX-API-DMAC7.html)
NZ707754B2 (en) Combination of glycopyrrolate and a beta2 -agonist
HK40000409B (en) Dry powder inhaler compositions of 7-azoniabicyclo[2.2.1]heptane derivatives
HK40000409A (en) Dry powder inhaler compositions of 7-azoniabicyclo[2.2.1]heptane derivatives